Marketing Growth Focus The leadership promotions and new hires in Fingerpaint Group signal a deliberate expansion of pharmaceutical marketing capabilities. This creates cross-sell opportunities for integrated digital marketing, demand generation, multi-channel campaigns, and regulatory-compliant content production across pharma clients. Propose reaching out to the marketing leadership to discuss end-to-end marketing services, digital ads optimization, and analytics.

Market Access Opportunity Fingerpaint's launch of a commercial support program to rapidly transition patients to a rare brain cancer therapy shows a growing emphasis on market access, payer strategy, and patient support. This opens opportunities to provide payer strategy, health economics and outcomes research, pricing, reimbursement consulting, and patient access programs as an expanded service line.

Tech Enablement The tech stack includes Google Cloud Platform, Amazon ECR, and development tooling that suggests readiness for cloud-native, data-driven pharma solutions. Potential offerings include cloud-driven data platforms, regulatory submission tooling, digital transformation, and AI-assisted content creation to streamline product development and commercialization.

Content and Creative With Adobe InDesign and PowerPoint handy, the firm demonstrates strong creative production capabilities for compliant pharma assets. Opportunities exist to upsell end-to-end content creation, global localization, regulatory-compliant asset development, and interactive digital media to support campaigns and product launches.

Ecosystem Advantage As part of Fingerpaint Group with leadership succession and industry recognition, there is potential to leverage the broader agency ecosystem to win larger pharma accounts. Propose cross-sell across marketing, market access, and technology services, expand geographic reach, and pursue integrated, end-to-end solutions.